C. Roedel

发表

Advance directives in radiation oncology: Attitudes of patients, physicians and nurses

J. Vollmann, M. Lang-Welzenbach, C. Roedel, 2008 .

MRI-Based Treatment of Rectal Cancer: Is Prognostication of the Recurrence Risk Solid Enough to Render Radiation Redundant?

W. Hohenberger, R. Sauer, R. Fietkau, 2013, Annals of Surgical Oncology.

Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial.

T. Hothorn, W. Hohenberger, R. Sauer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy

E. Ruppin, T. Beißbarth, Noam Auslander, 2022, British journal of cancer.

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

W. Hohenberger, C. Hess, C. Rödel, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial.

T. Hothorn, W. Hohenberger, R. Sauer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Theoretical Medicine

L. Mell, A. Mundt, D. Michalski, 2022 .

Evaluation of response after chemoradiation for rectal cancer as a predictive factor for the benefit of adjuvant chemotherapy: A pooled analysis of 2,724 individual patients.

C. Capirci, G. Beets, V. Valentini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

T. Zander, M. Shah, J. Izbicki, 2017, BMC Cancer.

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

T. Zander, M. Shah, J. Izbicki, 2017, BMC Cancer.

Neoadjuvant Capecitabine Combined with Standard Radiotherapy in Patients with Locally Advanced Rectal Cancer

J. Debus, A. Hinke, J. Wulf, 2008, Strahlentherapie und Onkologie.

Supratentorial Low-Grade Glioma: Results and Prognostic Factors Following Postoperative Radiotherapy

W. Huk, O. Ganslandt, R. Fahlbusch, 1999, Strahlentherapie und Onkologie.

Prognostic factors after neoadjuvant radiochemotherapy for rectal cancer: Update of the CAO/ARO/AIO-94 Phase III study

R. Sauer, R. Fietkau, P. Martus, 2005 .

Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapy

E. Ruppin, T. Beißbarth, Noam Auslander, 2022, British Journal of Cancer.

Local Recurrence and Survival for the German Centers in the TARGIT-A (TARGeted Intraoperative Radiation Therapy - Alone) Trial

M. Bremer, M. Baum, J. Vaidya, 2013 .

Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer - first results of the German multicenter phase-III-trial

R. Sauer, R. Fietkau, P. Martus, 2000 .

Lymphoedema, lymphatic microangiopathy and increased lymphatic and interstitial pressure in a patient with Parkinson's disease.

R. Koppensteiner, C. Roedel, M. Husmann, 1999, Schweizerische medizinische Wochenschrift.

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

T. Zander, M. Shah, J. Izbicki, 2017, BMC Cancer.

Tumor regression grading as prognostic factor in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy

R. Sauer, R. Fietkau, P. Martus, 2004 .